Herbalife (HLF) Cash & Equivalents (2009 - 2026)

Herbalife has disclosed Cash & Equivalents across 18 years of filings, most recently posting $370.5 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 7.83% year-over-year to $370.5 million; the TTM figure through Jun 2026 stood at $370.5 million (up 7.83% YoY), while the FY2025 annual figure was $353.1 million, down 19.4% from the prior year.
• Cash & Equivalents came in at $370.5 million for Q2 2026 at Herbalife, down from $451.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $595.5 million in Q4 2023 to a low of $305.5 million in Q3 2025.
• Average Cash & Equivalents over 5 years is $454.4 million, with a median of $444.6 million recorded in 2024.
• Year-over-year, Cash & Equivalents slumped 30.3% in 2022 and climbed 28.55% in 2026.
• Over 5 years, Cash & Equivalents stood at $516.3 million in 2022, then grew by 15.34% to $595.5 million in 2023, then declined by 26.43% to $438.1 million in 2024, then fell by 19.4% to $353.1 million in 2025, then increased by 4.93% to $370.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $370.5 million in Q2 2026, $451.2 million in Q1 2026, and $353.1 million in Q4 2025.